[Federal Register Volume 64, Number 161 (Friday, August 20, 1999)]
[Notices]
[Page 45556]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-21702]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel--Vancomycin Resistant S. aureus in
Dialysis Patients.
Date: August 30, 1999.
Time: 9:30 am to 10:30 am.
Agenda: To review and evaluate grant applications.
Place: NIAID, NIH (Room 2148), 6700-B Rockledge Drive, MSC 7610,
Bethesda, MD 20892-7610 (Telephone Conference Call).
Contact Person: Dianne E. Tingley, Scientific Review
Administrator, Scientific Review Program, Division of Extramural
Activities, NIAID, NIH, Room 2220, 6700-B Rockledge Drive, MSC 7610,
Bethesda, MD 20892-7610, 301-496-2550.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: August 13, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 99-21702 Filed 8-19-99; 8:45 am]
BILLING CODE 4140-01-M